Free Access
Issue
J Extra Corpor Technol
Volume 44, Number 2, June 2012
Page(s) 66 - 68
DOI https://doi.org/10.1051/ject/201244066
Published online 15 June 2012
  1. Sun JZ, Cao LH, Liu H. ACE inhibitors in cardiac surgery: Current studies and controversies. Hypertens Res. 2011;34:15–22. [CrossRef] [PubMed] [Google Scholar]
  2. Licker M, Neidhart P, Lustenberger S, et al. Long-term angiotensin-converting enzyme inhibitor treatment attenuates adrenergic responsiveness without altering hemodynamic control in patients undergoing cardiac surgery. Anesthesiology. 1996;84:789–800. [CrossRef] [PubMed] [Google Scholar]
  3. Packer M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation. 1999;100:2312–2318. [CrossRef] [PubMed] [Google Scholar]
  4. George RB, McKeen D, Columb MO, Habib AS. Up-down determination of the 90% effective dose of phenylephrine for the treatment of spinal anesthesia-induced hypotension in parturients undergoing cesarean delivery. Anesth Analg. 2010;110:154–158. [CrossRef] [PubMed] [Google Scholar]
  5. Mekontso-Dessap A, Houel R, Soustelle C, Kirsch M, Thebert D, Loisance DY. Risk factors for post-cardiopulmonary bypass vasoplegia in patients with preserved left ventricular function. Ann Thorac Surg. 2001;71:1428–1432. [CrossRef] [Google Scholar]
  6. Shanmugam G. Vasoplegic syndrome–the role of methylene blue. Eur J Cardiothorac Surg. 2005;28:705–710. [CrossRef] [Google Scholar]
  7. Noto A, Lentini S, Versaci A, et al. A retrospective analysis of terlipressin in bolus for the management of refractory vasoplegic hypotension after cardiac surgery. Interact Cardiovasc Thorac Surg. 2009;9:588–592. [CrossRef] [PubMed] [Google Scholar]
  8. Leyh RG, Kofidis T, Struber M, et al. Methylene blue: The drug of choice for catecholamine-refractory vasoplegia after cardiopulmonary bypass? J Thorac Cardiovasc Surg. 2003;125:1426–1431. [CrossRef] [Google Scholar]
  9. Maslow AD, Stearns G, Butala P, Schwartz CS, Gough J, Singh AK. The hemodynamic effects of methylene blue when administered at the onset of cardiopulmonary bypass. Anesth Analg. 2006;103:2–8. [CrossRef] [PubMed] [Google Scholar]
  10. Ramsay RR, Dunford C, Gilman PK. Methylene blue and serotonin inhibition of monamine oxidase A confirms theoretical prediction. Brit J Pharmacol. 2007;152:946–951. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.